News on Cheil Jedang Corporation - CJ Pharma from BioPortfolio.com http://www.BioPortfolio.com Consolidated Cheil Jedang Corporation - CJ Pharma news from BioPortfolio.com Wed, 10 Feb 2010 16:41:43 GMT en Report on market potential for RNA therapieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042593&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042593&THISHREF=http://c.moreover.com/click/here.pl%3fz2539469163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042593&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042593&THISHREF=http://c.moreover.com/click/here.pl%3fz2539469163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042495&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042495&THISHREF=http://c.moreover.com/click/here.pl%3fz2539436667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042495&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042495&THISHREF=http://c.moreover.com/click/here.pl%3fz2539436667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042328&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042328&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042328&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042328&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042326&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042326&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042326&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042326&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042355&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042355&THISHREF=http://c.moreover.com/click/here.pl%3fz2539400452%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042355&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042355&THISHREF=http://c.moreover.com/click/here.pl%3fz2539400452%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042273&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042273&THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042273&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042273&THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: Research and Markets: Company Financials Report: Schering-Plough Corporation Signed a $41.1 Billion Merger Agreement with its Bihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040949&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040949&THISHREF=http://c.moreover.com/click/here.pl%3fz2538940500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040949&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040949&THISHREF=http://c.moreover.com/click/here.pl%3fz2538940500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Research and Markets: Company Financials Report: Schering-Plough ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041121&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041121&THISHREF=http://c.moreover.com/click/here.pl%3fz2539001862%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041121&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041121&THISHREF=http://c.moreover.com/click/here.pl%3fz2539001862%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Research and Markets: Company Financials Report: Schering-Plough Corporation Signed a $41.1 Billion Merger Agreement with its Big Pharma Rival Merck & Co. in March 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041055&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041055&THISHREF=http://c.moreover.com/click/here.pl%3fz2538989713%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041055&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041055&THISHREF=http://c.moreover.com/click/here.pl%3fz2538989713%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Health Discovery Corporation Inks Deal for Final Validation of a New Molecular Diagnostic Test for Colon Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043217&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043217&THISHREF=http://c.moreover.com/click/here.pl%3fz2539653162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043217&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043217&THISHREF=http://c.moreover.com/click/here.pl%3fz2539653162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Health Discovery Corporation Inks Deal for Final Validation of a New Molecular Diagnostic Test for Colon Cancehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043588&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043588&THISHREF=http://c.moreover.com/click/here.pl%3fz2539787422%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043588&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043588&THISHREF=http://c.moreover.com/click/here.pl%3fz2539787422%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Health Discovery Corporation Inks Deal for Final Validation of a New Molecular Diagnostic Test for Colon Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043060&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043060&THISHREF=http://c.moreover.com/click/here.pl%3fz2539595425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043060&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043060&THISHREF=http://c.moreover.com/click/here.pl%3fz2539595425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Health Discovery Corporation Inks Deal for Final Validation of a New Molecular Diagnostic Test for Colon Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042874&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042874&THISHREF=http://c.moreover.com/click/here.pl%3fz2539540383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042874&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cheil%20Jedang%20Corporation%20-%20CJ%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042874&THISHREF=http://c.moreover.com/click/here.pl%3fz2539540383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: